In vitro activity of newer quinolones on Streptococcus pneumoniae isolated from outpatients.
Lontie
M
M
Liekens
K
K
Deschilder
I
I
D019980:Amoxicillin-Potassium Clavulanate Combination / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000494:pharmacology*; D002444:Cefuroxime / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology; D004318:Doxycycline / Q000494:pharmacology; D004359:Drug Therapy, Combination / Q000494:pharmacology; D024841:Fluoroquinolones; D006801:Humans; D009287:Naphthyridines / Q000494:pharmacology; D015242:Ofloxacin / Q000494:pharmacology; D010045:Outpatients; D010400:Penicillin G / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011008:Pneumococcal Infections / Q000382:microbiology*; D015363:Quinolones / Q000494:pharmacology; D015575:Roxithromycin / Q000494:pharmacology; D013296:Streptococcus pneumoniae / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002511:Cephalosporins; D024841:Fluoroquinolones; D009287:Naphthyridines; D010406:Penicillins; D010879:Piperazines; D015363:Quinolones; D015575:Roxithromycin; D019980:Amoxicillin-Potassium Clavulanate Combination; C080163:trovafloxacin; D015242:Ofloxacin; C075375:grepafloxacin; D004318:Doxycycline; D002444:Cefuroxime; D010400:Penicillin G